{ "docId": "019dd923-622c-750b-8b9a-101b5bfde4b8", "docSlug": "a70fecd99534", "documentTitle": "Berkeley Lights (BLI)", "authorId": "58_Scorpion_Capital", "authorName": "Scorpion Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2021-09-15 00:00:00", "orientation": "landscape", "aspectRatio": 1.2941177, "pageNumber": 155, "pageCount": 158, "prevPage": 154, "nextPage": 156, "slideType": "villain_critique", "function": "name_villain", "density": "dense", "nDataPoints": 4, "notes": "Uses direct quotes from former employees to build a case against the company's value proposition.", "elementsJson": [ "headline_text", "paragraph", "quote_block" ], "metadataConfidence": 1, "imagePath": null, "slideHref": "/slides/019dd923-622c-750b-8b9a-101b5bfde4b8/155", "deckHref": "/decks/019dd923-622c-750b-8b9a-101b5bfde4b8", "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-101b5bfde4b8.json", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-101b5bfde4b8#slide-155", "components": [ { "bbox": null, "kind": "callout", "text": "Former employees state that competing products at 5% of the cost - $100K vs. $2MM - have already rendered BLI obsolete: competitors are not only far cheaper but have higher throughput; another wave of even cheaper disruptors are on the horizon; a former scientist at BLI states he would rather use cheaper alternatives if he was at a biotech customer.", "attrs": null, "subkind": null, "toolName": "Visual emphasis", "toolSlug": "visual-emphasis", "confidence": null, "componentId": "019dd953-2042-70a9-a1b0-8e7e7a6d764d", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.15, "w": 0.9, "x": 0.05, "y": 0.12 }, "kind": "paragraph", "text": "Former employees state that competing products at 5% of the cost - $100K vs. $2MM - have already rendered BLI obsolete: competitors are not only far cheaper but have higher throughput; another wave of even cheaper disruptors are on the horizon; a former scientist at BLI states he would rather use cheaper alternatives if he was at a biotech customer.", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "059d73dc-dd82-405e-b7c2-570f770e13a0", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.08, "w": 0.85, "x": 0.08, "y": 0.33 }, "kind": "quote", "text": "One of the challenges that Berkeley Lights are facing in the coming years will be a lot of other companies will be entering into the same area and creating a lot of competition for the company. There are already other alternatives in the market.", "attrs": null, "subkind": "testimonial", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "51b94a4c-6b3d-4470-8417-5387510414f4", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.05, "w": 0.85, "x": 0.08, "y": 0.68 }, "kind": "quote", "text": "I would probably go with a cheaper machine and maybe a different set of assays from multiple platforms.", "attrs": null, "subkind": "testimonial", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "a06805ed-a8d0-49f0-8985-4beaf89e38b7", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.12, "w": 0.85, "x": 0.08, "y": 0.48 }, "kind": "quote", "text": "Nowadays especially, the field of single-cell analysis is expanding so much and making so much progress that I think we're getting to the point where most of the applications that are being developed on the platform can actually be replaced by applications with higher throughput on cheaper platforms like 10X Genomics and a couple of others.", "attrs": null, "subkind": "testimonial", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "b75fba66-dbc5-4139-a9e9-c76d2341dc47", "frameworkName": null, "frameworkSlug": null }, { "bbox": null, "kind": "quote", "text": "\"One of the challenges that Berkeley Lights are facing in the coming years will be a lot of other companies will be entering into the same area and creating a lot of competition for the company. There are already other alternatives in the market,\" — Former BLI engineer; \"Nowadays especially, the field of single-cell analysis is expanding so much and making so much progress that I think we're getting to the point where most of the applications that are being developed on the platform can actually be replaced by applications with higher throughput on cheaper platforms like 10X Genomics and a couple of others.\" — Former BLI scientist; \"I would probably go with a cheaper machine and maybe a different set of assays from multiple platforms.\" — Former BLI scientist", "attrs": null, "subkind": null, "toolName": "Authority citation", "toolSlug": "authority-citation", "confidence": null, "componentId": "019dd953-2042-70a9-a1b0-907b225e1953", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.03, "w": 0.3, "x": 0.05, "y": 0.95 }, "kind": "source-note", "text": "Source: Scorpion Capital consultation calls with experts", "attrs": null, "subkind": null, "toolName": null, "toolSlug": null, "confidence": null, "componentId": "bc2f07c6-0a38-4cd3-9a45-3df1aa237d2f", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.05, "w": 0.9, "x": 0.05, "y": 0.05 }, "kind": "title", "text": "Part 2) Former BLI employees/executives: Competition from cheaper, better alternatives has already rendered BLI irrelevant", "attrs": null, "subkind": "headline", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "d70bc8f5-7fd7-4e3f-8e51-cf8c6d3cff36", "frameworkName": null, "frameworkSlug": null } ], "metrics": [], "tools": [], "frameworks": [ { "name": "antagonist-introduction", "slug": null, "matchId": "9152b2eb-1a48-4cc7-9c50-1db094563950", "evidence": "Uses former employee testimonials to frame the company as obsolete due to competition.", "confidence": 0.9 } ], "arcBeats": [], "loops": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }